Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: BuySellSignals Research
$5.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ranbaxy Laboratories Ltd Announces No Plans To Reduce Workforce-Business Standard


Wednesday, 2 Oct 2013 06:18am EDT 

Business Standard reported that Ranbaxy Laboratories Ltd has no plans to reduce its workforce and is focusing on improving performance and productivity. Ranbaxy has no plans to reduce its workforce either in the next three or 12 months, a Ranbaxy spokesperson told PTI in an emailed response.